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Abstract
In China, Klebsiella pneumoniae carbapenemase (KPC) -producing K. pneumoniae isolates have been identiﬁed. However, little is known
about the spread and outbreak of KPC-producing enterobacterial pathogens. In this study, 48 non-duplicated KPC-producing isolates were
analysed for genetic relatedness by pulsed-ﬁeld gel electrophoresis (PFGE), antimicrobial susceptibility by E-test, and sequence type (ST) by
multilocus sequence typing. S1-PFGE and Southern blot were used for plasmid proﬁling, and PCR and subsequent sequencing were
performed to determine the effects of genetic background on the blaKPC gene. From December 2011 to June 2012, an outbreak of the
KPC-2-producing K. pneumoniae was observed. The 48 isolates of K. pneumoniae are categorized into eight PFGE types (A1, A2, A3, A4, B,
C, D and E). The predominant pathogens of the outbreak were strains with PFGE types A1, A2 and A3, which all belong to ST11.
Furthermore, ST37, ST392 and ST395 KPC-2-producing K. pneumoniae isolates have also been sporadically identiﬁed. The blaKPC-2-carrying
plasmids vary in size from 30 to 220 kb. The genetic environments of the blaKPC-2 gene for most strains were consistent with the genetic
structure of blaKPC-2 on the plasmid pKP048. In conclusion, the dissemination and outbreak of KPC-2-producing K. pneumoniae isolates in
this study appeared to be clonal, and ST11 K. pneumoniae was the predominant clone attributed to the outbreak. This is the ﬁrst study to
report the emergence and spread of KPC-producing K. pneumoniae ST392 and ST395 worldwide. Our ﬁndings suggest that horizontal
transfer of Tn3-based transposons might mediate the spread of blaKPC-2 gene between different K. pneumoniae clones in China.
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Introduction
The emergence and dissemination of carbapenem-resistant
Enterobacteriaceae posed an important growing public
health threat [1–5]. Among various determinants sustaining
resistance to carbapenems, variants of Klebsiella pneumoniae
carbapenemases (KPCs) have comprised the largest and most
prevalent group of class A carbapenem-hydrolysing enzymes in
Enterobacteriaceae. The blaKPC genes have been detected
among various bacterial species, and KPC-producing patho-
gens have been detected worldwide after identiﬁcation of the
ﬁrst KPC variant (KPC-2) in 1996 [1,2]. In China, KPC-pro-
ducing K. pneumoniae isolates have been identiﬁed [6–15]. An
outbreak of blaKPC-carrying K. pneumoniae has been observed
in the Zhejiang province, involving 28 patients in an intensive
care unit (ICU) over a 6-month period [15]. Among these
KPC-producing K. pneumoniae isolates, the single variant
identiﬁed was blaKPC-2, whereas other blaKPC alleles were
not detected. The blaKPC-2 gene is located on bacterial
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plasmids with size of about 40–180 kb, and coexist with other
resistance determinants in clinical K. pneumoniae isolates from
China, such as blaTEM, blaSHV, blaCTX-M, blaDHA, blaIMP, qnr, aac
(6’)-Ib-cr and rmtB [6,7,9–15].
As founders of clonal complex 258 (CC258), K. pneumoniae
sequence type 11 (ST11) and its single-locus (tonB) variant,
ST258, have spread globally and are signiﬁcantly associated with
the worldwide dissemination of KPC-producing K. pneumoniae
[16]. ST258 is the predominant clone observed in European
countries and the USA [16–18], while ST11 is the prevalent
clone associated with the spread of KPC-producing K. pneumo-
niae in China [12]. Meanwhile, other blaKPC-carrying K. pneu-
moniae clones—including ST15, ST23, ST349, ST 351, ST438,
ST439 and ST476—have been identiﬁed in China [9,12,13].
Genetic structures surrounding the blaKPC gene are mostly
associated with two transposon-related structures. One is a
Tn3-based transposon, Tn4401, which is about 10 kb in size
and is composed of a transposase gene, a resolvase gene, the
blaKPC gene and two insertion sequences (ISKpn6 and ISKpn7)
[19]. Currently, ﬁve isoforms of Tn4401 have been identiﬁed
which differ by various upstream deletions of the blaKPC gene
[20]. Another genetic structure related to the blaKPC gene is
also a Tn3-based transposon, which contains an integration
structure of Tn3-based transposon and partial Tn4401
segment, with a substitution of ISKpn8 for ISKpn7 [8]. This
structure was ﬁrst identiﬁed on the plasmid pKP048 (GenBank
No. FJ628167) from a clinical K. pneumoniae isolate. Several
variants have been found among Enterobacteriaceae in China
that contain various fragment insertions (most are truncated
blaTEM) between the ISKpn8 and the blaKPC coding region
[8,12,13,21–23].
In this study, we report a nosocomial outbreak of
KPC-2-producing K. pneumoniae isolates at our hospital, which
involved 44 patients and covered three ICUs, and one surgical
and medical ward. The molecular and epidemiological features
of KPC-2-producing K. pneumoniae isolates and of the blaKPC-2
gene were also analysed.
Materials and Methods
Bacterial strains
Since 2009, all clinical K. pneumoniae strains isolated from a
4000-bed tertiary-care hospital were collected. All clinical
isolates were identiﬁed using VITEK 2 GN ID cards (bioMerie-
ux, Inc., Hazelwood, MO, USA) and VITEK MS (bioMerieux
SA, Marcy-l’Etoile, France). The isolates that exhibited
non-susceptibility to carbapenems were screened for blaKPC
gene by PCR ampliﬁcation. Escherichia coli ATCC 25922 was
used as the quality control strain for antimicrobial suscepti-
bility testing. Salmonella ser. Braenderup strain (H9812) was
used as a reference standard of pulsed-ﬁeld gel electrophoresis
(PFGE). The sodium azide-resistant E. coli J53 strain was used
as the recipient for conjugation testing.
Antimicrobial susceptibility testing
The MICs of cefotaxime, cefepime, piperacillin–tazobactam,
imipenem, meropenem, ertapenem, amikacin and levoﬂoxacin
were measured by E-test (AB bioMerieux, Solna, Sweden). All
protocols were performed according to the manufacturer’s
instructions. The modiﬁed Hodge test was performed for
suspected KPC production in K. pneumoniae isolates. All
susceptibility results were interpreted according to the 2012
CLSI performance standards [24].
Molecular detection of resistance genes
b-lactamase genes including blaKPC, blaTEM, blaSHV, blaCTX-M,
blaPER, blaVEB, blaGES and plasmid-mediated quinolone resis-
tance genes, including qnrA, qnrB, qnrC, qnrD, qnrS, qepA, oqxAB
and aac(6’)-Ib-cr, and 16S rRNA methylase genes, including
armA, rmtA, rmtB, rmtC and rmtD were screened by several
multiplex PCR methods as previously described [25].
PFGE analysis
PFGE typing of KPC-producing isolates was performed as
described by the US Centers for Disease Control and
Prevention PulseNet program [26]. DNA ﬁngerprints were
obtained from PFGE proﬁles of genomic DNA digested with
XbaI (New England Biolabs, Ipswich, MA, USA). The PFGE
patterns were analysed by BIONUMERICS software (Applied
Maths NV, Sint-Martens-Latem, Belgium) using the dice
similarity coefﬁcient. Strains were considered as the same
clone (type) if they possessed ≥85% genetic similarity or fewer
than four fragment differences in PFGE proﬁles [27]. Clusters
were deﬁned as DNA patterns sharing ≥70% similarity.
Plasmid analysis and Southern blot
A blaKPC probe was constructed by labelling a blaKPC PCR
product through the PCR DIG Probe Synthesis Kit (Roche
Applied Sciences, Mannheim, Germany). The S1-PFGE and
Southern blot were performed as previously described [28].
Conjugation testing
Conjugation experiments were performed in Luria–Bertani
broth. Cultures of donor and recipient cells in the logarithmic
phase (0.5 mL of each) were added to 4 mL of fresh Luria–
Bertani broth and incubated overnight without shaking.
Transconjugants were selected on China blue agar plates
containing meropenem (1 mg/L) and sodium azide (200 mg/L;
Sigma-Aldrich Co., St Louis, MO, USA).
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Multilocus sequence typing
Multilocus sequence typing was carried out for all PFGE types
of K. pneumoniae isolates by amplifying and sequencing of seven
housekeeping genes according to protocols provided on the
multilocus sequence typing website for K. pneumoniae (http://
www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.
html). All ampliﬁcation products were sequenced on a DNA
analyser (3730xl; Applied Biosystems, Life Technologies,
Foster City, CA, USA).
Genetic environment analysis of blaKPC gene
The genetic background of the blaKPC gene was investigated
with a PCR mapping approach. Ampliﬁcations were performed
using speciﬁc primers targeting the context of the blaKPC gene
[8]. All ampliﬁcation products were sequenced in a DNA
analyser (3730xl; Applied Biosystems, Life Technologies).
Results
Emergence and outbreak of KPC-2-producing strains
In this study, the strains that were isolated from different
patients or different sites of the same patient were deﬁned as
non-duplicated strains. In total, 48 non-duplicated KPC-2-pro-
ducing K. pneumoniae strains were isolated from 44 patients,
which covered three ICUs, and one surgical and medical ward
(Fig. 2). All of them were positive for Hodge test. Among these
isolates, 25 (52%) were isolated from sputum samples, while
two, three, three, seven and eight strains were isolated from
bile, venous cannula, drainage ﬂuid, urine sample and
blood, respectively. The KPC-2-producing K. pneumoniae iso-
lates were detected between February 2009 and November
2011. During this period, 1636 non-duplicated K. pneumoniae
strains were isolated from various clinical specimens. In
general, KPC-positive K. pneumoniae was presented at low
prevalence (2.9%; 48/1636) at our hospital. An outbreak was
observed in the next 7 months (December 2011 to June 2012)
(Figs 1 and 2). A relatively higher prevalence of KPC-producing
K. pneumoniae was observed during the outbreak, where
11.7% (41/351) of K. pneumoniae isolates were KPC-positive.
According to the medical diagnosis on death, 12 of 44 (27%)
patients with KPC-2-producing K. pneumoniae isolates died,
and infection caused by KPC-2-producing K. pneumoniae
strains continues to be a leading cause of death, including
two urinary tract, one bloodstream, one biliary and eight
pulmonary infections. Thirty patients (68%) showed improve-
ment and two patients were discharged. For the eight patients
with bloodstream infections caused by KPC-2-producing
K. pneumoniae isolates, one died and the others showed
improvement or were discharged.
PFGE and multilocus sequence typing analysis
The 48 isolates of K. pneumoniae are categorized into ﬁve
PFGE clusters (A to E). Cluster A contains four types (A1 to
A4) while only one type was categorized among the other
clusters. The distribution of KPC-2-producing isolates with
different PFGE types is shown in Fig. 2. Cluster A comprises
the majority of KPC-2-producing K. pneumoniae strains asso-
ciated with the outbreak (variant types A1 to A4). Type A1
was the most prevalent strain that disseminated across all ﬁve
wards, followed by types A2, A3 and D strain. Before
November 2011, types A3 and D strains were scattered and
identiﬁed in two wards, while a type E isolate was detected
twice in ward II and has not emerged since. In a period of
FIG. 1. The distribution of the KPC-2-producing Klebsiella pneumoniae isolates.
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7 months (December 2011 to June 2012), types A1 (23
isolates), A2 (ﬁve isolates) and A3 (eight isolates) strains were
detected in an outbreak at two medical ICUs (ward I and II)
and one surgical ward (ward III). Types A4 (one isolate), B
(three isolates), C (one isolate) D (ﬁve isolates) and E (two
isolates) strains were found in three wards (II, III and IV).
Besides the type B strain, which was isolated from three
specimens of the same patient, only type A1 was detected in
wards IV and V (Fig. 2). Four sequence types (STs) were
identiﬁed among K. pneumoniae isolates carrying blaKPC-2.
Types A1, A2, A3, A4 and type C strains belonged to ST11,
while type B was categorized with ST37. Type D and E were
also identiﬁed as ST395 and ST392, respectively (Table 1).
Antimicrobial susceptibilities
The MICs of common antimicrobial agents tested against all
types of KPC-2-producing K. pneumoniae isolates are shown in
Table 1. All isolates were resistant to oxyimino-cephalosporins
(cefotaxime and cefepime) and carbapenems including imipe-
nem, meropenem and ertapenem. Type A2, A3 and C isolates
exhibited high-level amikacin resistance, while most isolates
(except type B) presented resistance to levoﬂoxacin (Table 1).
Prevalence of resistant determinants
Table 1 display the prevalence of common resistance deter-
minants among each type of isolates. Type A1 strain did not
produce any 16S rRNA methylase and was sensitive to
amikacin, whereas type A2 and A3 strains were resistant to
amikacin, but carried armA and rmtB, respectively. Further-
more, although most strains produced CTX-M, signiﬁcant
differences were exhibited in the prevalence of various
resistant determinants. All isolates were negative for blaPER,
blaVEB, blaGES, qnrA, qnrC, qnrD, rmtA, rmtC, rmtD and npmA.
Conjugation of plasmids
Only IR1301 (type A1) and IR131 (type B) transferred the
blaKPC-2-carrying plasmids to the recipient by conjugation, and
no transconjugants were collected for the other types of
FIG. 2. The distribution of the KPC-2-producing Klebsiella pneumoniae isolates with different pulsed ﬁeld gel electrophoresis type among clinical
wards. The date, frequency and location of emergence of different KPC-2-producing K. pneumoniae strains were shown in the Table. The head shows
the date on which KPC-2-producing K. pneumoniae strains were isolated. The serial numbers of wards are listed in the ﬁrst column. Different types of
clinical isolates are indicated by the following symbols: ■:type A1; □: type A2;▲: type A3;△: type A4; ●: type B;〇: type C; ⊙: type D; ◎: type
E. The outbreak period is shown between the grey rows.
TABLE 1. Phenotypic and genotypic characteristics of KPC-2-producing Klebsiella pneumoniae isolates
PFGE
type
MLST
type
Number
of isolate
Size of
plasmids
carrying
blaKPC-2
Genetic
environment
of blaKPC-2 Resistance determinants
Minimal inhibitory concentration (mg/L)
CTX FEP TZP IPM MEM ETP AMK LEV
A1 ST 11 23 ~220 kb Consistent with
pKP048a
blaSHV, blaCTX-M-group 9, qnrS >256 >256 >256 >32 >32 >32 0.75 >32
A2 ST 11 5 ~140 kb Consistent with
pKP048a
blaSHV, blaTEM, blaCTX-M-group 1,
armA
>256 >256 >256 >32 >32 >32 >256 >32
A3 ST 11 8 ~120 kb Consistent with
pKP048a
blaSHV, blaTEM, blaCTX-M-group 1,
blaCTX-M-group 9, qnrS, rmtB
>256 >256 >256 >32 >32 >32 >256 >32
A4 ST 11 1 ~120 kb Consistent with
pKP048a
blaSHV, qnrB >256 >256 >256 >32 >32 >32 2 >32
B ST 37 3 ~40 kb Variant 1 blaSHV, blaOXA-1-like, blaCTX-M-group 1,
qnrB, aac(6’)-Ib-cr, oqxAB
>256 32 >256 12 8 32 8 0.5
C ST 11 1 ~130 kb Consistent with
pKP048a
blaSHV, blaTEM, blaOXA-1-like, qnrB,
oqxAB, armA
>256 >256 >256 >32 >32 >32 >256 >32
D ST 395 5 ~50 kb and ~120 kb Consistent with
pKP048a
blaSHV, blaCTX-M-group 9, qnrB,
aac(6’)-Ib-cr, oqxAB
>256 >256 >256 >32 >32 >32 4 >32
E ST 392 2 ~30 kb Variant 2 blaSHV, blaTEM, blaCTX-M-group 1,
aac(6’)-Ib-cr, oqxAB
>256 >256 >256 >32 >32 >32 4 >32
MLST, multilocus sequence typing; CTX, cefotaxime; FEP, cefepime; TZP, piperacillin–tazobactam; IMP, imipenem; MEM, meropenem; ETP, ertapenem; AMK, amikacin; LEV,
levoﬂoxacin.
aGenBank accession number: FJ628167 [5].
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K. pneumoniae isolates. The MICs of the transconjugants of
IR1301 and IR131 are as follow: cefotaxime (>256 and 12 mg/
L), cefepime (6 and 2 mg/L), piperacillin–tazobactam (>256 and
128 mg/L), imipenem (4 and 4 mg/L), meropenem (1.5 and
1 mg/L), ertapenem (2 and 1.5 mg/L), amikacin (1 and 1 mg/L)
and levoﬂoxacin (0.023 and 0.023 mg/L).
Plasmid analysis
S1-PFGE and Southern blot analysis showed that all types of
clinical K. pneumoniae isolates carried plasmids of different size.
Furthermore, the blaKPC-2 gene was located on various
plasmids, with size ranging from approximately 30 kb to
220 kb. Strains IR1304 (type A3), IR1215 (type A4) and IR1205
(type D) contained blaKPC-2-carrying plasmids with similar sizes
(about 120 kb). Interestingly, besides the 120 kb-size of
plasmid, another blaKPC-2-carrying plasmid with size of 50 kb
coexisted in the strain IR1205.
Genetic environment of blaKPC gene
Most plasmids encode for structural components, which was
consistent with the background of the blaKPC-2 gene in the
plasmid pKP048 [8]. Inserted fragments of 321 and 259 bp in
truncated blaTEM were detected upstream of the blaKPC-2 gene
for strain IR1314 (type B) and IR1201 (type E), respectively.
(Fig. 3 and Table 1).
Discussion
KPC-producing K. pneumoniae isolates have been sporadically
reported across China [6–14]. In this study, 2.9% of clinical
K. pneumoniae isolates produced KPC-2, so KPC-producing
K. pneumoniae exhibited relatively low prevalence in China
compared with some European countries and the USA [3–5].
In this study, 12 of 44 (27%) patients died, with KPC-2-
producing K. pneumoniae being a possible cause of death.
However, most patients suffered from a serious underlying
disease and presented with severe conditions. It is difﬁcult to
determine whether patients will succumb to infections asso-
ciated with KPC-producing K. pneumoniae. Other studies have
reported a higher mortality rate associated with bloodstream
infections and no data are shown correlating patient survival
with carbapenem dosage [29–31]. Therefore, it seems that
mortality was more associated with the clinical conditions of
the patients upon infection.
In this study, type A1 was the most prevalent strain that
disseminated across all ﬁve wards. The multilocus sequence
typing analysis demonstrated that the type A1 strain was ST11
(Table 1). Therefore, the dissemination of KPC-producing
K. pneumoniae isolates in this study appeared to be clonal.
This is consistent with a previous report showing that ST11 is
the most prevalent clone in China [12]. Recently, KPC-
producing K. pneumoniae ST11 was also identiﬁed in other
parts of Asia, including Taiwan, Singapore and Korea, as well
as European and American countries, including Greece, Brazil,
the UK and Poland. ST11 belongs to the clone complex 258
(CC258) and possesses a single-locus variance (tonB) from
ST258 [16]. As members of a complex, ST258 has been
implicated in over 70% of all outbreaks of KPC-producing
K. pneumoniae in the USA [18], whereas ST11 contributed
signiﬁcantly to the dissemination of the KPC-2-producing
K. pneumoniae in Asia. Furthermore, ST11 was associated
FIG. 3. Schematic representation of the genetic structures surrounding the blaKPC-2 gene. Various genes and their directions of transcription are
presented as broad arrows. The area delimited by two dotted lines indicates identical regions. * Pulsed ﬁeld gel electrophoresis types.
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with the spread and outbreak of K. pneumoniae producing
OXA-48 and NDM-1 [32,33]. It has been speculated that
CC258 might spread rapidly worldwide [12]. The K. pneumoniae
CC258 also produces proteins involved in cell motility,
secretion and DNA repair and modiﬁcation, which might
contribute to its rapid spread worldwide [34]. As for other
KPC-producing K. pneumoniae STs, ST37 and ST392 did not
spread in our hospital. ST395 (PFGE type D) was isolated
from ﬁve patients and had a limited spread in ward II (Fig. 2).
Recently, KPC-producing K. pneumoniae ST37 has been
detected sporadically in other areas of the world [35,36],
and ST392 and ST395 have been reported to have contrib-
uted to the dissemination of blaOXA-48 in Europe [37]. To
date, this is the ﬁrst study to report about the emergence and
spread of KPC-producing K. pneumoniae ST392 and ST395
worldwide.
Generally, KPCs alone do not confer resistance but are
able to reduce the susceptibility to carbapenems, and
impaired outer-membrane permeability contributes to the
ineffectiveness of carbapenems for most KPCs [2]. In this
study, most of the clinical strains exhibited a high-level of
resistance to carbapenems (Table 1), whereas the two
transconjugants exhibited low-level resistance to IPM and
ETP, but were susceptible to MEM. These observations
indicated that the carbapenem-resistant phenotype is attrib-
uted to the combination of KPCs and other mechanisms. In
this study, the clinical strains exhibited different phenotypic
and genotypic characterization (Table 1). Furthermore, the
blaKPC-2-carrying plasmids vary dramatically in size among
the different strains. The different plasmid proﬁles suggested
that the spread of blaKPC-2 gene was not mediated by
plasmid exchange between different strains. Altogether, the
independent evolutionary processes and the clonal transmis-
sion of KPC-2-producing K. pneumoniae isolates may exist in
China.
In this study, the blaKPC-2-carrying plasmids vary dramat-
ically in size among the different strains. The different plasmid
proﬁles suggested that the spread of the blaKPC-2 gene was
not mediated by plasmid exchange between strains of
different type, but by the clonal transmission of KPC-2-pro-
ducing K. pneumoniae isolates in China. The genetic environ-
ment of the blaKPC gene has been characterized as a
transposon-associated element, named Tn4401 [19]. Until
recently, ﬁve isoforms of Tn4401, which differ by polymor-
phisms located upstream of the blaKPC gene, have been
identiﬁed [20]. Meanwhile, a distinct genetic background of
the blaKPC-2 gene located on the plasmid pKP048 has been
identiﬁed in China, which contains an integration structure of
a Tn3-based transposon and partial Tn4401 segment, with the
gene order Tn3-transposase, Tn3-resolvase, ISKpn8, the
blaKPC-2 gene and the ISKpn6-like element [8]. For most
strains analysed in this study, the genetic environment of the
blaKPC-2 is consistent with pKP048. Likewise, for most
KPC-2-producing Enterobacteriaceae isolated from China, the
genetic environments of the blaKPC-2 were also Tn3-based
transposons similar to pKP048, with or without an inserted
fragment of truncated blaTEM located upstream of the blaKPC
gene [8,12,13,21–23]. Although the region upstream of the
blaKPC gene is variable, Tn4401 possesses genes that encode
for transposase (tnpA) and resolvase (tnpR) activity, and have
been characterized as an active transposon that is able to
mobilize the blaKPC genes at high frequency without target
speciﬁcity [38]. For K. pneumoniae and other common
enterobacterial pathogens isolated from China, the Tn3-based
transposons surrounding blaKPC-2 gene have accordant trans-
posal structure compared with Tn4401. This suggests that the
spread of the blaKPC-2 gene between different K. pneumoniae
strains in China might be mediated by horizontal transfer of
Tn3-based transposons but not by transmission of
blaKPC-2-carrying plasmids.
The present study has several limitations. First, limited
patient information was available for discriminating between
infection with KPC-producing K. pneumoniae and colonization
or transient carrier. Second, the outer-membrane permeabil-
ities of KPC-producing K. pneumoniae isolates have not been
analysed. Third, the type of blaKPC-carrying plasmids has not
been characterized. Fourth, except for blaKPC, the types of
other resistance genes were not identiﬁed.
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